Medication reviews by a clinical pharmacist at an Irish university teaching hospital

dc.contributor.authorKearney, Alan
dc.contributor.authorHalleran, Ciaran
dc.contributor.authorWalsh, Elaine K.
dc.contributor.authorByrne, Derina
dc.contributor.authorHaugh, Jennifer
dc.contributor.authorSahm, Laura J.
dc.date.accessioned2018-02-06T13:36:28Z
dc.date.available2018-02-06T13:36:28Z
dc.date.issued2017
dc.description.abstractPurpose: Pharmacist-led medication reviews in hospitals have shown improvement in patient outcomes. The aim of this study is to describe the prevalence and nature of pharmacist interventions (PIs) following a medication review in an Irish teaching hospital. Methods: PIs were recorded over a six-month period in 2015. PIs were assessed by a panel of healthcare professionals (n = 5) to estimate the potential of adverse drug events (ADEs). Descriptive statistics were used for the variables and the chi square test for independence was used to analyse for any association between the variables. Results: Of the 1216 patients (55.8% female; median age 68 years (interquartile range 24 years)) who received a medication review, 313 interventions were identified in 213 patients. 412 medicines were associated with PIs, of which drugs for obstructive airway disease (n = 82), analgesics (n = 56), and antibacterial products for systemic use (n = 50) were the most prevalent. A statistically significant association was found between PI and patient’s age ≥65 years (p = 0.000), as well as female gender (p = 0.037). A total of 60.7% of the PIs had a medium or high likelihood of causing an ADE. Conclusion: Pharmacist-led medication review in a hospital setting prevented ADEs. Patients ≥65 years of age and female patients benefited the most from the interventions.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid60
dc.identifier.citationKearney, A., Halleran, C., Walsh, E., Byrne, D., Haugh, J. and Sahm, L. (2017) 'Medication reviews by a clinical pharmacist at an Irish university teaching hospital', Pharmacy, 5(4), 60 (10pp). doi: 10.3390/pharmacy5040060en
dc.identifier.doi10.3390/pharmacy5040060
dc.identifier.endpage10
dc.identifier.issn2226-4787
dc.identifier.issued4
dc.identifier.journaltitlePharmacyen
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/10468/5389
dc.identifier.volume5
dc.language.isoenen
dc.publisherMDPI AGen
dc.relation.urihttp://www.mdpi.com/2226-4787/5/4/60
dc.rights© 2017, the authors. Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHospital pharmacyen
dc.subjectPharmacist interventionen
dc.subjectMedication reviewen
dc.subjectAdverse drug eventen
dc.subjectIrelanden
dc.titleMedication reviews by a clinical pharmacist at an Irish university teaching hospitalen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
4150.pdf
Size:
396.13 KB
Format:
Adobe Portable Document Format
Description:
Published Version